Search

Charu Ramakrishnan Phones & Addresses

  • 6410 Almaden Ave, San Jose, CA 95120 (408) 997-1664
  • 6314 Paso Los Cerritos, San Jose, CA 95120
  • 339 Albert Dr, Vernon Hills, IL 60061 (847) 367-8224
  • 7148 Dexter Rd, Downers Grove, IL 60516 (847) 435-1807
  • Pittsburgh, PA
  • Ann Arbor, MI
  • Lane, IL
  • 6314 Paso Los Cerritos, San Jose, CA 95120 (408) 997-1664

Work

Company: Stanford university Apr 2008 Position: Manager, deisseroth lab

Education

School / High School: Poona University 1983 to 1987 Specialities: Molecular Biology

Skills

Molecular Biology • Cell Culture • Molecular Cloning • Cell Biology • Microbiology • Transfection • Tissue Culture • Neuroscience • Dna • Gel Electrophoresis • Cell • Confocal Microscopy • Pcr • Fluorescence Microscopy • Immunohistochemistry • Microscopy • Life Sciences • Sequencing • Science • Lifesciences • Laboratory • Protein Expression • In Vitro • Rt Pcr • Teaching • Experimentation • Genetics • Elisa • Virology • Sds Page • Purification • Bioinformatics • Immunofluorescence • Mutagenesis • Molecular Genetics • Physiology • Histology • Fluorescence • Bioengineering • Rna Isolation • Immunoprecipitation • Dna Extraction • Site Directed Mutagenesis • Recombinant Dna Technology • Enzyme Assays

Languages

English • Hindi

Interests

Football • Exercise • Sweepstakes • Home Improvement • Shooting • Reading • Sports • Watching Basketball • Home Decoration • Watching Sports • Photograph • Cooking • Electronics • Outdoors • Sewing • Crafts • Fitness • Music • Camping • Movies • Kids • Joggin • 科学技術 • Walking • Travel • Wine • Investing • Basketball • Tennis • Watching Football

Industries

Biotechnology

Resumes

Resumes

Charu Ramakrishnan Photo 1

Manager, Deisseroth Lab

View page
Location:
6314 Paso Los Cerritos, San Jose, CA 95120
Industry:
Biotechnology
Work:
Stanford University
Manager, Deisseroth Lab

Deisseroth Lab
Manager

Northwestern University Jan 2002 - Oct 2002
Manager, Molecular Biology and Sequencing Core

University of Michigan Medical School Jan 1992 - May 1995
Research Associate
Education:
Poona University 1983 - 1987
Department of Technology, Savitribai Phule Pune University 1983 - 1985
Master of Science, Masters, Molecular Biology
Kendriya Vidyalaya 1978 - 1980
Skills:
Molecular Biology
Cell Culture
Molecular Cloning
Cell Biology
Microbiology
Transfection
Tissue Culture
Neuroscience
Dna
Gel Electrophoresis
Cell
Confocal Microscopy
Pcr
Fluorescence Microscopy
Immunohistochemistry
Microscopy
Life Sciences
Sequencing
Science
Lifesciences
Laboratory
Protein Expression
In Vitro
Rt Pcr
Teaching
Experimentation
Genetics
Elisa
Virology
Sds Page
Purification
Bioinformatics
Immunofluorescence
Mutagenesis
Molecular Genetics
Physiology
Histology
Fluorescence
Bioengineering
Rna Isolation
Immunoprecipitation
Dna Extraction
Site Directed Mutagenesis
Recombinant Dna Technology
Enzyme Assays
Interests:
Football
Exercise
Sweepstakes
Home Improvement
Shooting
Reading
Sports
Watching Basketball
Home Decoration
Watching Sports
Photograph
Cooking
Electronics
Outdoors
Sewing
Crafts
Fitness
Music
Camping
Movies
Kids
Joggin
科学技術
Walking
Travel
Wine
Investing
Basketball
Tennis
Watching Football
Languages:
English
Hindi

Publications

Us Patents

Compositions And Methods For Controlling Production Of Polypeptides In Cells

View page
US Patent:
20230064644, Mar 2, 2023
Filed:
Feb 3, 2021
Appl. No.:
17/796839
Inventors:
- Stanford CA, US
Charu Ramakrishnan - San Jose CA, US
Yoon Seok Kim - Stanford CA, US
Lief E. Fenno - Palo Alto CA, US
International Classification:
C12N 15/85
C12N 15/66
Abstract:
The present disclosure provides recombinant expression vectors for modulating production of polypeptides of interest in a target cell or target cell population. Aspects of the disclosure include recombinant expression vectors having coding sequences encoding portions of a polypeptide of interest, where the coding sequences are flanked by recombinase recognition sites. Also provided are methods for using the recombinant expression vectors as well as a device for monitoring expression of the polypeptide of interest.

Activity-Dependent Expression Constructs And Methods Of Using The Same

View page
US Patent:
20200318079, Oct 8, 2020
Filed:
May 23, 2017
Appl. No.:
16/303903
Inventors:
- Stanford CA, US
Li Ye - Palo Alto CA, US
Charu Ramakrishnan - San Jose CA, US
Kimberly R. Thompson - Palo Alto CA, US
International Classification:
C12N 7/00
C12N 15/86
A61K 48/00
A61K 49/00
Abstract:
The present disclosure provides nucleic acid activity-dependent expression vectors and activity-dependent expression cassettes for the activity-dependent expression of an encoded polypeptide. Also provided are recombinant adenoassociated viruses (AAV) containing an expression vector comprising an activity-dependent expression cassette for the activity-dependent expression of an encoded polypeptide by cells infected with the AAV vector. The present disclosure also provides methods for the activity-dependent labeling of cells in vitro or in vivo by introducing into the cells an expression vector containing an activity-dependent regulatory sequence driving expression of a labeling polypeptide. Also provided are methods for the activity-dependent control of cells in vitro or in vivo by introducing into the cells an expression vector containing an activity-dependent regulatory sequence driving expression of a light-responsive polypeptide.

Engineered Light-Activated Anion Channel Proteins And Methods Of Use Thereof

View page
US Patent:
20200030446, Jan 30, 2020
Filed:
Oct 11, 2019
Appl. No.:
16/600076
Inventors:
- Stanford CA, US
Soo Yeun Lee - Stanford CA, US
Charu Ramakrishnan - Stanford CA, US
Andre Berndt - Stanford CA, US
International Classification:
A61K 41/00
C07K 14/47
A61N 5/06
Abstract:
Aspects of the disclosure include compositions, devices, systems and methods for optogenetic modulation of action potentials in target cells. The subject devices include light-generating devices, control devices, and delivery devices for delivering light-responsive polypeptides, or nucleic acids encoding same, to target cells. The subject compositions and systems include light-activated polypeptides, nucleic acids comprising nucleotide sequences encoding these polypeptides, as well as expression systems that facilitate expression of these polypeptides in target cells. Also provided are methods of using the subject devices and systems to optogenetically manipulate action potentials in target cells, e.g., to treat a neurological or psychiatric condition in a human or animal subject.

Dopamine Receptor Type 2 Specific Promoter And Methods Of Use Thereof

View page
US Patent:
20200032291, Jan 30, 2020
Filed:
Sep 27, 2019
Appl. No.:
16/586524
Inventors:
- Stanford CA, US
Charu Ramakrishnan - San Jose CA, US
Kelly Zalocusky - Mountain View CA, US
International Classification:
C12N 15/85
C07K 14/705
C07K 14/435
C12N 9/12
Abstract:
A nucleic acid containing a dopamine receptor type 2-specific promoter (D2SP) is provided. In certain embodiments, the nucleic acid includes a dopamine receptor type 2-specific promoter (D2SP), wherein the D2SP does not include exon 1 of a D2 receptor gene, wherein the D2SP comprises a Kozak sequence, and wherein the D2SP includes a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 1. Also provided are expression vectors, genetically modified host cells and kits that include the subject nucleic acid.

Calcium Indicator Polypeptides And Methods Of Use Thereof

View page
US Patent:
20180372762, Dec 27, 2018
Filed:
May 25, 2018
Appl. No.:
15/990132
Inventors:
- Stanford CA, US
Charu Ramakrishnan - San Jose CA, US
Masatoshi Inoue - Stanford CA, US
International Classification:
G01N 33/84
C07K 14/47
G01N 33/58
Abstract:
The present disclosure provides a genetically encoded calcium indicator (GECI), nucleic acids encoding the GECI, and host cells comprising the GECI. The present disclosure also provides methods of detecting a change in the intracellular concentration of a cell expressing a GECI of the present disclosure.

Engineered Light-Activated Anion Channel Proteins And Methods Of Use Thereof

View page
US Patent:
20180344851, Dec 6, 2018
Filed:
Aug 7, 2018
Appl. No.:
16/057639
Inventors:
- Stanford CA, US
Soo Yeun Lee - Stanford CA, US
Charu Ramakrishnan - Stanford CA, US
Andre Berndt - Stanford CA, US
International Classification:
A61K 41/00
C07K 14/47
A61K 38/00
Abstract:
Aspects of the disclosure include compositions, devices, systems and methods for optogenetic modulation of action potentials in target cells. The subject devices include light-generating devices, control devices, and delivery devices for delivering light-responsive polypeptides, or nucleic acids encoding same, to target cells. The subject compositions and systems include light-activated polypeptides, nucleic acids comprising nucleotide sequences encoding these polypeptides, as well as expression systems that facilitate expression of these polypeptides in target cells. Also provided are methods of using the subject devices and systems to optogenetically manipulate action potentials in target cells, e.g., to treat a neurological or psychiatric condition in a human or animal subject.

Light-Responsive Polypeptides And Methods Of Use Thereof

View page
US Patent:
20180250402, Sep 6, 2018
Filed:
Sep 14, 2016
Appl. No.:
15/756936
Inventors:
- Stanfod CA, US
Andre Berndt - Mountain View CA, US
Soo Yeun Lee - Palo Alto CA, US
Charu Ramakrishnan - San Jose CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
A61K 41/00
C07K 14/00
A61N 5/06
Abstract:
The present disclosure provides variant light-responsive polypeptides, and nucleic acids comprising nucleotide sequences encoding the light-responsive polypeptides. The present disclosure provides methods, devices, and systems for controlling the activity of a cell expressing a variant light-responsive polypeptide of the present disclosure.

Dopamine Receptor Type 2 Specific Promoter And Methods Of Use Thereof

View page
US Patent:
20170327841, Nov 16, 2017
Filed:
Dec 3, 2015
Appl. No.:
15/531965
Inventors:
- Stanford CA, US
Charu Ramakrishnan - San Jose CA, US
Kelly Zalocusky - Mountain View CA, US
International Classification:
C12N 15/85
C07K 14/705
C07K 14/435
C12N 9/12
Abstract:
A nucleic acid containing a dopamine receptor type 2-specific promoter (D2SP) is provided. In certain embodiments, the nucleic acid includes a dopamine receptor type 2-specific promoter (D2SP), wherein the D2SP does not include exon 1 of a D2 receptor gene, wherein the D2SP comprises a Kozak sequence, and wherein the D2SP includes a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 1. Also provided are expression vectors, genetically modified host cells and kits that include the subject nucleic acid.
Charu A Ramakrishnan from San Jose, CA, age ~61 Get Report